Lipocalin-type prostaglandin D synthase is a powerful biomarker for severity of stable coronary artery disease

Atherosclerosis

Volumn 201, Issue 2, 2008, Pages 385-391

  Inoue, Teruo ^a   Eguchi, Yutaka ^b   Matsumoto, Tetsuya ^b   Kijima, Yoshiyuki ^c   Kato, Yoji ^d   Ozaki, Yukio ^e   Waseda, Katsuhisa ^f   Oda, Hiroshi ^g   Seiki, Kosuke ^g   Node, Koichi ^a   Urade, Yoshihiro ^h  

^a SAGA UNIVERSITY   (Japan)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c OSAKA CITY GENERAL HOSPITAL   (Japan)

^d Ishinkai Yao General Hospital   (Japan)

^e FUJITA HEALTH UNIVERSITY   (Japan)

^f AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g Maruha Nichiro Holdings Inc   (Japan)

^h JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Atherosclerosis; Biomarker; Coronary artery disease; Lipocalin type prostaglandin D synthase; Prostaglandin D2

Indexed keywords

BIOLOGICAL MARKER; LIPOCALIN; PROSTAGLANDIN D SYNTHASE; PROSTAGLANDIN D2;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD SAMPLING; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIAGNOSTIC VALUE; DISEASE SEVERITY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENSINI SCORE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCORING SYSTEM; SCREENING;

AGED; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CORONARY ARTERY DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; LIPOCALINS; MALE; MIDDLE AGED; PROSTAGLANDIN D2; REGRESSION ANALYSIS; RISK FACTORS; ROC CURVE;

EID: 54249093581     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.03.010     Document Type: Article

References (24)

1. 2: a biochemical perspective. Prostaglandins Leukot Essent Fatty Acids 37 (1989) 219-234
2. 2 and sleep regulation. Biochim Biophys Acta 1436 (1999) 606-615
3. 2 in sleep-wake regulation: recent progress and perspectives. Neuroscientist 8 (2002) 12-15
4. Eguchi N., Minami T., Shirafuji N., et al. Lack of tactile pain (allodynia) in lipocalin-type prostaglandin D synthase-deficient mice. Proc Natl Acad Sci USA 96 (1999) 726-730
5. 2: differential sensitivity of platelet transduction processes and functional response to inhibition by cyclic AMP. Biochem J 232 (1985) 267-271
6. Negishi M., Sugimoto Y., and Ichikawa A. Prostanoid receptors and their biological actions. Prog Lipid Res 32 (1993) 417-434
7. Urade Y., Fujimoto N., and Hayaishi O. Purification and characterization of rat brain prostaglandin D synthase. J Biol Chem 260 (1985) 12410-12415
8. Hoffmann A., Conradt H.S., Gross G., et al. Purification and chemical characterization of β-trace protein from human cerebrospinal fluid: its identification as prostaglandin D synthase. J Neurochem 61 (1993) 451-456
9. Watanabe K., Urade Y., Mäder M., Murphy C., and Hayaishi O. Identification of β-trace as prostaglandin D synthase. Biochem Biophys Res Commun 203 (1994) 1110-1116
10. Eguchi Y., Eguchi N., Oda H., et al. Expression of lipocalin-type prostaglandin D synthase (β-trace) in human heart and its accumulation in the coronary circulation of angina patients. Proc Natl Acad Sci USA 94 (1997) 14689-14894
11. Oda H., Eguchi N., and Urade Y. Quantitative sandwich enzyme-linked immunosorbent assay for human secretory prostagrandin D synthase (β-trace). Proc Japan Acad 72 (1996) 108-111
12. Oda H., Shiina Y., Seiki K., et al. Development and evaluation of a practical ELISA for human urinary lipocalin-type prostaglandin D synthase. Clin Chem 48 (2002) 1445-1453
13. Yamashima T., Sakuda K., Tohma Y., et al. J Neurosci 17 (1997) 2376-2382
14. Gensini G.G. Coronary arteriography. In: Braunwald E. (Ed). Heart disease (1984), WB Sanders, Philadelphia 343
15. Tokugawa Y., Kunishige I., Kubota Y., et al. Lipocalin-type prostaglandin D synthase in human male reproductive organs and seminal plasma. Biol Reprod 58 (1998) 600-607
16. Weinstein M.C., and Fineberg H.V. Clinical decision analysis (1984), WB Sanders, Philadelphia p. 114-27
17. 2 synthase expression in vascular endothelial cells. Circ Res 86 (2000) 967-973
18. Inoue T., Takayanagi K., Morooka S., et al. Serum prostaglandin D synthase level after coronary angioplasty may predict occurrence of restenosis. Thromb Haemost 85 (2001) 165-170
19. Melegos D.N., Grass L., Pierratos A., and Diamandis E.P. Highly elevated levels of prostaglandin D synthase in the serum of patients with renal failure. Urology 53 (1999) 32-37
20. Hoffmann A., Nimtz M., and Conradt H.S. Molecular characterization of beta-trace protein in human serum and urine: a potential diagnostic marker for renal diseases. Glycobiology 7 (1997) 499-506
21. 2 inhibits inducible nitric oxide synthase expression in rat vascular smooth muscle cells. Circ Res 82 (1998) 204-209
22. Forman B.M., Tontonoz P., Chen J., et al. 15-Deoxy-delta 12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83 (1995) 803-812
23. 2 synthase knock-out mice. J Biol Chem 280 (2005) 29946-29955
24. Wakino S., Kintscher U., Kim S., et al. Retinoids inhibit proliferation of human coronary smooth muscle cells by modulating cell cycle regulators. Arterioscler Thromb Vasc Biol 21 (2001) 746-751